- Home
- MYNZ vs AEMD Comparison
MYNZ vs AEMD Comparison
Compare MYNZ & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- AEMD
- Stock Information
- Founded
- MYNZ 2021
- AEMD 1984
- Country
- MYNZ Germany
- AEMD United States
- Employees
- MYNZ N/A
- AEMD N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- AEMD Medical/Dental Instruments
- Sector
- MYNZ Health Care
- AEMD Health Care
- Exchange
- MYNZ Nasdaq
- AEMD Nasdaq
- Market Cap
- MYNZ 6.1M
- AEMD 6.1M
- IPO Year
- MYNZ 2021
- AEMD N/A
- Fundamental
- Price
- MYNZ $0.24
- AEMD $0.40
- Analyst Decision
- MYNZ Buy
- AEMD Strong Buy
- Analyst Count
- MYNZ 2
- AEMD 1
- Target Price
- MYNZ $3.00
- AEMD $7.00
- AVG Volume (30 Days)
- MYNZ 5.2M
- AEMD 413.8K
- Earning Date
- MYNZ 11-26-2024
- AEMD 11-13-2024
- Dividend Yield
- MYNZ N/A
- AEMD N/A
- EPS Growth
- MYNZ N/A
- AEMD N/A
- EPS
- MYNZ N/A
- AEMD N/A
- Revenue
- MYNZ $917,203.00
- AEMD N/A
- Revenue This Year
- MYNZ $36.69
- AEMD N/A
- Revenue Next Year
- MYNZ $91.67
- AEMD N/A
- P/E Ratio
- MYNZ N/A
- AEMD N/A
- Revenue Growth
- MYNZ 16.23
- AEMD N/A
- 52 Week Low
- MYNZ $0.19
- AEMD $0.24
- 52 Week High
- MYNZ $1.79
- AEMD $2.35
- Technical
- Relative Strength Index (RSI)
- MYNZ 45.71
- AEMD 50.18
- Support Level
- MYNZ $0.22
- AEMD $0.38
- Resistance Level
- MYNZ $0.36
- AEMD $0.46
- Average True Range (ATR)
- MYNZ 0.04
- AEMD 0.03
- MACD
- MYNZ 0.00
- AEMD 0.00
- Stochastic Oscillator
- MYNZ 18.59
- AEMD 33.15
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.